Principal Scientist, DMPK
Calico
This listing was originally posted on Calico's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moCalico (Calico Life Sciences LLC) is an Alphabet-founded research and development company whose mission is to harness advanced technologies and model systems to increase our understanding of the biology that controls human aging. Calico will use that knowledge to devise interventions that enable people to lead longer and healthier lives. Calico’s highly innovative technology labs, its commitment to curiosity-driven discovery science and, with academic and industry partners, its vibrant drug-development pipeline, together create an inspiring and exciting place to catalyze and enable medical breakthroughs.
Position Description:
Calico is seeking a Principal Scientist, Drug Metabolism and Pharmacokinetics to join our Drug Discovery team. This position is a unique opportunity to shape the DMPK strategy and contribute to the development of innovative therapeutics. This role will function as an individual contributor, collaborating closely with external partners such as Pharma and CROs.
Position Responsibilities:
Strategic Leadership
Collaboration and Outsourcing
Individual Contribution
Position Requirements:
Nice To Have:
The estimated base salary range for this role is $197,000 - $235,000. Actual pay will be based on a number of factors including experience and qualifications. This position is also eligible for two annual cash bonuses.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Calico?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Aging treatments
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo